(Press-News.org) Women, older people and minorities are enrolled less frequently in lung cancer drug trials and the numbers do not reflect the prevalence of lung cancer in these populations, according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC).
"Our results suggest that the trial population used for approval of drugs do not represent well the U.S. population who may receive the marketed agent," said principal investigator Dr. Shakun Malik, a medical officer at the U.S. Food and Drug Administration (FDA) in Silver Spring, Maryland.
Researchers reviewed trial data submitted for FDA drug approvals for the treatment of non-small cell lung cancer (NSCLC) over the last decade.
Of U.S. patients diagnosed with lung cancer according to the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) data released on April 15, 2011, and collected between years 1975-2008, 58% were men and 42% women. But in 10 national and international trials for agents approved to treat NSCLC between January 2000 and December 2010, 68% of enrollees were men and 32% were women.
In addition, 73% of U.S. lung cancer patients are older than 65 but only 36% of the drug trial population was older than 65, researchers found.
Meanwhile, African-Americans develop lung cancer at higher rates (72.7 per 100,000) than Caucasians (68 per 100,000), but only 2% of trial participants were black. Caucasians made up 78% of the trial population, Asians 15%, Hispanics 2% and "other" 2%.
"Disparity was especially pronounced in the age and ethnicity," Dr. Malik wrote. "This fact is concerning particularly for older patients who may experience greater toxicity when given the same dose and combination of drugs based on testing in a younger population."
INFORMATION:Dr. Shakun Malik will discuss the research with journalists during a WCLC press conference at 10 a.m. CET on Wednesday, July 6. For individual interview requests, please call Renée McGaw at +31 20 549 3413 between July 3-7 in the press office at Amsterdam RAI, Amsterdam, the Netherlands. You may also email her at renee.mcgaw@ucdenver.edu
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC), based in Denver, Colorado, U.S.A., is the only global organization dedicated to the study of lung cancer. Founded in 1972, the association's membership includes more than 3,000 lung cancer specialists in 80 countries.
IASLC members promote the study of etiology, epidemiology, prevention, diagnosis, treatment and all other aspects of lung cancer and thoracic malignancies. IASLC disseminates information about lung cancer to scientists, members of the medical community and the public, and uses all available means to eliminate lung cancer as a health threat for the individual patients and throughout the world. Membership is open to any physician, health professional or scientist interested in lung cancer.
IASLC publishes the Journal of Thoracic Oncology, a valuable resource for medical specialists and scientists who focus on the detection, prevention, diagnosis and treatment of lung cancer. To learn more about IASLC please visit http://iaslc.org/
END
New developments such as stereotactic ablative radiotherapy and improvements in surgical care in early-stage lung cancer have led to large survival gains for elderly Dutch patients, according to a population-based study presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC).
The median survival for Dutch non-small cell lung cancer (NSCLC) patients increased by nearly 8 months between 2003 and 2009, following the advent of stereotactic ablative radiotherapy.
"In fit patients, surgery ...
Increased investment in specialist thoracic surgical expertise can lead to a significant rise in the lung cancer resection rate, based on data from England between 2008 and 2009 that was presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC).
In England, lung cancer resection is less common than in other countries, and is performed by
both cardiothoracic and pure thoracic surgeons. Researchers tested the hypotheses that resection rate was related to the caseload and local provision ...
PHILADELPHIA — Celecoxib may emerge as a potent chemopreventive agent for lung cancer, according to a recent study in Cancer Prevention Research, a journal of the American Association for Cancer Research.
Researchers tested celecoxib, a COX-2 inhibitor, among patients who were former smokers and found a significant benefit in bronchial health as measured by the Ki-67 labeling index, a marker of cellular proliferation or growth, as well as a number of other biomarkers. The findings follow a previous report published in Cancer Prevention Research that showed a similar effect ...
(Deerfield, Ill., USA - July 6, 2011) A cheap, common heartworm medication that is already being used to fight other parasites in Africa could also dramatically interrupt transmission of malaria, potentially providing an inexpensive tool to fight a disease that kills almost 800,000 people each year, according to a new study published today in the July edition of the American Journal of Tropical Medicine and Hygiene.
The study by scientists from Senegal and Colorado State University found that transmission of malaria parasites by mosquitoes fell substantially among people ...
Professional development workshops for college teachers, designed to encourage the use of active, "learner-centered" teaching methods, may be less effective than the participants believe, according to research reported in the July issue of BioScience.
Diane Ebert-May of Michigan State University and her colleagues studied the teaching of participants in two such established programs for faculty teaching introductory biology courses. Although after the workshops most of the faculty judged themselves to be providing the favored, learner-centered teaching, which encourages ...
Gray whales survived many cycles of global cooling and warming over the past few million years, likely by exploiting a more varied diet than they do today, according to a new study by University of California, Berkeley, and Smithsonian Institution paleontologists.
The researchers, who analyzed California gray whale (Eschrichtius robustus) responses to climate change over the past 120,000 years, also found evidence to support the idea that the population of gray whales along the Pacific Coast before the arrival of humans was two to four times today's population, which ...
More than 99 per cent of modern vertebrates (animals with a backbone, including humans) have jaws, yet 420 million years ago, jawless, toothless armour-plated fishes dominated the seas, lakes, and rivers. There were no vertebrates yet on land and the recently evolved jawed fishes were minor players in this alien world, some sporting unusual jaw shapes and structures that bear little physical resemblance to modern animals.
The researchers, led by Dr Philip Anderson of Bristol's School of Earth Sciences, applied concepts from physics and engineering to unravel the potential ...
BOULDER, Colo. – Showcasing new tools for widespread development of quantum circuits made of mechanical parts, scientists from the National Institute of Standards and Technology (NIST) have demonstrated a flexible, broadly
usable technique for steadily calming the vibrations of an engineered mechanical object down to the quantum "ground state," the lowest
possible energy level.
Described in a Nature paper posted online July 6,* the NIST experiments nearly stop the beating motion of a microscopic aluminum drum made of about 1 trillion atoms, placing the drum in a realm ...
Results from a study of over 50 000 pregnancies revealed that women who gave up smoking when their pregnancy was confirmed gave birth to babies with a similar birthweight to those born to mothers who had never smoked, Professor Nick Macklon, from the Department of Obstetrics and Gynaecology, University of Southampton, UK, told the annual conference of the European Society of Human Reproduction and Embryology today (Wednesday).
Low birthweight is the most common negative outcome of smoking during pregnancy, but foetuses exposed to maternal smoking are also at risk of premature ...
The group looked at 60,650 singletons in a common Nordic database from ART registers in Denmark, Finland, Norway and Sweden and compared these to a control group of 360,022 naturally conceived (NC) singletons. In both groups 0.4 % of singletons were stillborn, with a definition of stillbirth as a dead child after 22 weeks of gestation. After having been matched with the control group regarding mother's parity and year of birth, the overall risk of stillbirth was found to be marginally higher (1.1 fold) in ART children after adjusting for factors such as maternal age and ...
